-
1
-
-
0025283961
-
Developmental cell death: Morphological diversity and multiple mechanisms
-
Clarke, P G. H. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryll. 181, 195-213 (1990).
-
(1990)
Anat. Embryll.
, vol.181
, pp. 195-213
-
-
Clarke, P.G.H.1
-
2
-
-
0013483293
-
Cell death and diseases of the nervous system
-
Koliatsos, V E. & Ratan, R. R., Humana Press, New Jersey
-
Clarke, P. G. H. Cell death and diseases of the nervous system (eds Koliatsos, V E. & Ratan, R. R.) 3-28 (Humana Press, New Jersey, 1999).
-
(1999)
, vol.3-28
-
-
Clarke, P.G.H.1
-
3
-
-
0034687754
-
An alternative, nonapoptotic form of programmed cell death
-
Sperandio, S., de Belle, I. & Bredesen, D. E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl Acad. Sci. USA 97, 14376-14381 (2000).
-
(2000)
Proc. Natl Acad. Sci. USA
, vol.97
, pp. 14376-14381
-
-
Sperandio, S.1
De Belle, I.2
Bredesen, D.E.3
-
4
-
-
0028878716
-
Expression of bcl-2 inhibits necrotic neural cell death
-
Kane, D. J., Ord, T, Anton, R. & Bredesen, D. E. Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40, 269-275 (1995).
-
(1995)
J. Neurosci. Res.
, vol.40
, pp. 269-275
-
-
Kane, D.J.1
Ord, T.2
Anton, R.3
Bredesen, D.E.4
-
5
-
-
0036162719
-
Apoptosis: A guide for the perplexed
-
Sloviter, R. S. Apoptosis: a guide for the perplexed. Trends Pharmacol. Sci. 23, 19-24 (2002).
-
(2002)
Trends Pharmacol. Sci.
, vol.23
, pp. 19-24
-
-
Sloviter, R.S.1
-
6
-
-
0031738971
-
DNA fragmentation in human substantia nigra: Apoptosis or perimortem effect?
-
Kingsbury, A. E., Mardsen, C. D. & Foster, O. J. DNA fragmentation in human substantia nigra: apoptosis or perimortem effect? Mov. Disord. 13, 877-884 (1998).
-
(1998)
Mov. Disord.
, vol.13
, pp. 877-884
-
-
Kingsbury, A.E.1
Mardsen, C.D.2
Foster, O.J.3
-
7
-
-
0035929569
-
New leads on the 'how' of Alzheimer's
-
Marx, J. New leads on the 'how' of Alzheimer's. Science 293, 2192-2194 (2001).
-
(2001)
Science
, vol.293
, pp. 2192-2194
-
-
Marx, J.1
-
8
-
-
0035122040
-
Programmed cell death in cerebral ischemia
-
Graham, S. H. & Chen, J. Programmed cell death in cerebral ischemia. J. Cereb. Blood Flow Metab. 21, 99-109 (2001).
-
(2001)
J. Cereb. Blood Flow Metab.
, vol.21
, pp. 99-109
-
-
Graham, S.H.1
Chen, J.2
-
9
-
-
0037248298
-
Neurodegeneration: What is it and where are we?
-
Przedborski, S., Vila, M. & Jackson-Lewis, V. Neurodegeneration: what is it and where are we? J. Clin. Invest. 111, 3-10 (2003).
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 3-10
-
-
Przedborski, S.1
Vila, M.2
Jackson-Lewis, V.3
-
10
-
-
0032579490
-
An induced proximity model for caspase-8 activation
-
Muzio, M., Stockwell, B. R., Stennicke, H. R., Salvesen, G. S. & Dixit, V. M. An induced proximity model for caspase-8 activation. J. Biol. Chem. 273, 2926-2930 (1998).
-
(1998)
J. Biol. Chem.
, vol.273
, pp. 2926-2930
-
-
Muzio, M.1
Stockwell, B.R.2
Stennicke, H.R.3
Salvesen, G.S.4
Dixit, V.M.5
-
11
-
-
0030715323
-
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
-
Li, P. et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489 (1997).
-
(1997)
Cell
, vol.91
, pp. 479-489
-
-
Li, P.1
-
12
-
-
0033179760
-
BCL-2 family members and the mitochondria in apoptosis
-
Gross, A., McDonnell, J. M. & Korsmeyer, S. J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911 (1999).
-
(1999)
Genes Dev
, vol.13
, pp. 1899-1911
-
-
Gross, A.1
McDonnell, J.M.2
Korsmeyer, S.J.3
-
13
-
-
0036728834
-
Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics
-
Letai, A. et al. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183 (2002).
-
(2002)
Cancer Cell
, vol.2
, pp. 183
-
-
Letai, A.1
-
14
-
-
0037057629
-
Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf- 1/caspase-9 apoptosome
-
Marsden, V. S. et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf- 1/caspase-9 apoptosome. Nature 419, 634-637 (2002).
-
(2002)
Nature
, vol.419
, pp. 634-637
-
-
Marsden, V.S.1
-
15
-
-
0036685522
-
Inflammation in neurodegenerative disease — a double-edged sword
-
Wyss-Coray, T. & Mucke, L. Inflammation in neurodegenerative disease — a double-edged sword. Neuron 35, 419-432 (2002).
-
(2002)
Neuron
, vol.35
, pp. 419-432
-
-
Wyss-Coray, T.1
Mucke, L.2
-
16
-
-
0033601746
-
Ordering the cytochrome c-initiated caspase cascade: Hierarchical activation of caspase-2,-3,-6,-7,-8, and-10 in a caspase-9-dependent manner
-
Slee, E. A. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspase-2,-3,-6,-7,-8, and-10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281-292 (1999).
-
(1999)
J. Cell Biol.
, vol.144
, pp. 281-292
-
-
Slee, E.A.1
-
17
-
-
0033280669
-
Biochemical pathways of caspase activation during apoptosis
-
Budihardjo, I., Oliver, H., Lutter, M., Luo, X & Wang, X. Biochemical pathways of caspase activation during apoptosis. Annu. Rev. Cell Dev. Biol. 15, 269-290 (1999).
-
(1999)
Annu. Rev. Cell Dev. Biol.
, vol.15
, pp. 269-290
-
-
Budihardjo, I.1
Oliver, H.2
Lutter, M.3
Luo, X.4
Wang, X.5
-
18
-
-
0034616945
-
Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition
-
Du, C., Fang, M., Li, Y, Li, L. & Wang, X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33-42 (2000).
-
(2000)
Cell
, vol.102
, pp. 33-42
-
-
Du, C.1
Fang, M.2
Li, Y.3
Li, L.4
Wang, X.5
-
19
-
-
0034616942
-
Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins
-
Verhagen, A. M. et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43-53 (2000).
-
(2000)
Cell
, vol.102
, pp. 43-53
-
-
Verhagen, A.M.1
-
20
-
-
0034710649
-
Structural and biochemical basis of apoptotic activation by Smac/DIABLO
-
Chai, J. et al. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 406, 855-862 (2000).
-
(2000)
Nature
, vol.406
, pp. 855-862
-
-
Chai, J.1
-
21
-
-
0034680876
-
Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway
-
Srinivasula, S. M. et al. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. J Biol. Chem. 275, 36152-36157 (2000).
-
(2000)
J Biol. Chem.
, vol.275
, pp. 36152-36157
-
-
Srinivasula, S.M.1
-
22
-
-
0033521741
-
Molecular characterization of mitochondrial apoptosis-inducing factor
-
Susin, S. A. et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397, 441-446 (1999).
-
(1999)
Nature
, vol.397
, pp. 441-446
-
-
Susin, S.A.1
-
23
-
-
0035811496
-
Endonuclease G is an apoptotic DNase when released from mitochondria
-
Li, L. Y, Luo, X. & Wang, X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412, 95-99 (2001).
-
(2001)
Nature
, vol.412
, pp. 95-99
-
-
Li, L.Y.1
Luo, X.2
Wang, X.3
-
24
-
-
0037159784
-
Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans
-
Wang, X., Yang, C., Chai, J., Shi, Y. & Xue D. Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science 298, 1587-1592 (2002).
-
(2002)
Science
, vol.298
, pp. 1587-1592
-
-
Wang, X.1
Yang, C.2
Chai, J.3
Shi, Y.4
Xue, D.5
-
25
-
-
0034610743
-
Caspase-12 mediates endoplasmic- reticulum-specific apoptosis and cytotoxicity by amyloid-p
-
Nakagawa, T et al. Caspase-12 mediates endoplasmic- reticulum-specific apoptosis and cytotoxicity by amyloid-p. Nature 403, 98-103 (2000).
-
(2000)
Nature
, vol.403
, pp. 98-103
-
-
Nakagawa, T.1
-
26
-
-
0037072937
-
An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12
-
Morishima, N., Nakanishi, K, Takenouchi, H., Shibata, T & Yasuhiko, Y An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J. Biol. Chem. 277, 34287-34294 (2002).
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 34287-34294
-
-
Morishima, N.1
Nakanishi, K.2
Takenouchi, H.3
Shibata, T.4
Yasuhiko, Y.5
-
27
-
-
0037418843
-
BAX and BAK regulation of endoplasmic reticulum Ca2+: A control point for apoptosis
-
Mar 6
-
2+: a control point for apoptosis. Science 2003 Mar 6 (DOI 10.1126/science.1081208).
-
(2003)
Science
-
-
Scorrano, L.1
-
28
-
-
0004109776
-
Merritt's neurology
-
Rowland, L P, Lippincott, Williams & Wilkins, New York
-
Fahn, S. & Przedborski, S. Merritt's neurology (ed. Rowland, L P) 679-693 (Lippincott, Williams & Wilkins, New York, 2000).
-
(2000)
, pp. 679-693
-
-
Fahn, S.1
Przedborski, S.2
-
29
-
-
0029942337
-
Histochemical detection of apoptosis in Parkinson's disease
-
Mochizuki, H., Goto, K, Mori, H. & Mizuno, Y. Histochemical detection of apoptosis in Parkinson's disease. J. Neurol. Sci. 137, 120-123 (1996).
-
(1996)
J. Neurol. Sci.
, vol.137
, pp. 120-123
-
-
Mochizuki, H.1
Goto, K.2
Mori, H.3
Mizuno, Y.4
-
30
-
-
0031036896
-
Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
-
Anglade, P. et al. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histo!. Histopatho!. 12, 25-31 (1997).
-
(1997)
Histo!. Histopatho!.
, vol.12
, pp. 25-31
-
-
Anglade, P.1
-
31
-
-
0031696403
-
A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease
-
Tatton, N. A., Maclean-Fraser, A., Tatton, W. G., Perl, D. P & Olanow, C. W. A fluorescent double-labeling method to detect and confirm apoptotic nuclei in Parkinson's disease. Ann. Neurol. 44, S142-S148 (1998).
-
(1998)
Ann. Neurol.
, vol.44
, pp. S142-S148
-
-
Tatton, N.A.1
Maclean-Fraser, A.2
Tatton, W.G.3
Perl, D.P.4
Olanow, C.W.5
-
32
-
-
0031013141
-
Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons
-
Tompkins, M. M., Basgall, E. J., Zamrini, E. & Hill, W. D. Apoptotic-like changes in Lewy-body-associated disorders and normal aging in substantia nigral neurons. Am. J. Pathol. 150, 119-131 (1997).
-
(1997)
Am. J. Pathol.
, vol.150
, pp. 119-131
-
-
Tompkins, M.M.1
Basgall, E.J.2
Zamrini, E.3
Hill, W.D.4
-
33
-
-
1842297607
-
On the question of apoptosis in the parkinsonian substantia nigra
-
Kosel, S., Egensperger, R., Von Eitzen, U., Mehraein, P & Graeber, M. B. On the question of apoptosis in the parkinsonian substantia nigra. Acta Neuropatho!. (Berl.) 93. 105-108 (1997).
-
(1997)
Acta Neuropatho!. (Berl.)
, vol.93
, pp. 105-108
-
-
Kosel, S.1
Egensperger, R.2
Von Eitzen, U.3
Mehraein, P.4
Graeber, M.B.5
-
34
-
-
0031930771
-
Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease
-
Banati, R. B., Daniel, S. E. & Blunt, S. B. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov. Disord. 13, 221-227 (1998).
-
(1998)
Mov. Disord.
, vol.13
, pp. 221-227
-
-
Banati, R.B.1
Daniel, S.E.2
Blunt, S.B.3
-
35
-
-
0342331476
-
Cell death and apoptosis regulating proteins in Parkinson's disease — a cautionary note
-
Wullner, U. et al. Cell death and apoptosis regulating proteins in Parkinson's disease — a cautionary note. Acta Neuropathol. (Berl.) 97, 408-412 (1999).
-
(1999)
Acta Neuropathol. (Berl.)
, vol.97
, pp. 408-412
-
-
Wullner, U.1
-
36
-
-
0035103294
-
Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease?
-
Hartmann, A. et al. Is Bax a mitochondrial mediator in apoptotic death of dopaminergic neurons in Parkinson's disease? J. Neurochem. 76, 1785-1793 (2001).
-
(2001)
J. Neurochem.
, vol.76
, pp. 1785-1793
-
-
Hartmann, A.1
-
37
-
-
0033756901
-
Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease
-
Tatton, N. A. Increased caspase 3 and Bax immunoreactivity accompany nuclear GAPDH translocation and neuronal apoptosis in Parkinson's disease. Exp. Neurol. 166, 29-43 (2000).
-
(2000)
Exp. Neurol.
, vol.166
, pp. 29-43
-
-
Tatton, N.A.1
-
38
-
-
12944250987
-
Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease
-
Hartmann, A. et al. Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. Proc. Nat Acad. Sci. USA 97, 2875-2880 (2000).
-
(2000)
Proc. Nat Acad. Sci. USA
, vol.97
, pp. 2875-2880
-
-
Hartmann, A.1
-
39
-
-
0036311251
-
Increased expression and redistribution of the antiapoptotic molecule BcI-xl in Parkinson's disease
-
Hartmann, A. et al. Increased expression and redistribution of the antiapoptotic molecule BcI-xl in Parkinson's disease. NeuroBiol. Dis. 10, 28-32 (2002).
-
(2002)
Neurobiol. Dis.
, vol.10
, pp. 28-32
-
-
Hartmann, A.1
-
40
-
-
0035313071
-
Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis
-
Hartmann, A. et al. Caspase-8 is an effector in apoptotic death of dopaminergic neurons in Parkinson's disease, but pathway inhibition results in neuronal necrosis. J. Neurosci. 21, 2247-2255 (2001).
-
(2001)
J. Neurosci.
, vol.21
, pp. 2247-2255
-
-
Hartmann, A.1
-
41
-
-
0035894881
-
Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1- methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease
-
Viswanath, V. et al. Caspase-9 activation results in downstream caspase-8 activation and bid cleavage in 1- methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced Parkinson's disease. J. Neurosci. 21, 9519-9528 (2001).
-
(2001)
J. Neurosci.
, vol.21
, pp. 9519-9528
-
-
Viswanath, V.1
-
42
-
-
0033681149
-
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
-
Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nature Neurosci. 3, 1301 -1306 (2000).
-
(2000)
Nature Neurosci
, vol.3
-
-
Betarbet, R.1
-
43
-
-
0037314540
-
Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
-
Hoglinger, G. U. et al. Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats. J. Neurochem. 84, 1-12 (2003).
-
(2003)
J. Neurochem.
, vol.84
, pp. 1-12
-
-
Hoglinger, G.U.1
-
44
-
-
0034681471
-
Dopaminergic loss and inclusion body formation in a-synuclein mice: implications for neurodegenerative disorders
-
Masliah, E. et al. Dopaminergic loss and inclusion body formation in a-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269 (2000).
-
(2000)
Science
, vol.287
, pp. 1265-1269
-
-
Masliah, E.1
-
45
-
-
0034663176
-
Neuropathology in mice expressing human a-synuclein
-
van der Putten, H. et al. Neuropathology in mice expressing human a-synuclein. J. Neurosci. 20, 6021-6029 (2000).
-
(2000)
J. Neurosci.
, vol.20
, pp. 6021-6029
-
-
Van Der Putten, H.1
-
46
-
-
0034704752
-
A Drosophila model of Parkinson's disease
-
Feany, M. B. & Bender W. W. A Drosophila model of Parkinson's disease. Nature 404, 394-398 (2000).
-
(2000)
Nature
, vol.404
, pp. 394-398
-
-
Feany, M.B.1
Bender, W.W.2
-
47
-
-
0034979314
-
Lack of nigral pathology in transgenic mice expressing human a-synuclein driven by the tyrosine hydroxylase promoter
-
Matsuoka, Y et al. Lack of nigral pathology in transgenic mice expressing human a-synuclein driven by the tyrosine hydroxylase promoter. NeuroBiol. Dis. 8, 535-539 (2001).
-
(2001)
Neurobiol. Dis.
, vol.8
, pp. 535-539
-
-
Matsuoka, Y.1
-
48
-
-
0037173006
-
Human a-synudein-harboring familial Parkinson's disease-linked Ala-53-Thr mutation causes neurodegenerative disease with a-synuclein aggregation in transgenic mice PG-8968-73
-
Lee, M. K et al. Human a-synudein-harboring familial Parkinson's disease-linked Ala-53-Thr mutation causes neurodegenerative disease with a-synuclein aggregation in transgenic mice PG-8968-73. Proc. Natl Acad. Sci. USA 99, 8968-73 (2002).
-
(2002)
Proc. Natl Acad. Sci. USA
, vol.99
, pp. 8968-8973
-
-
Lee, M.K.1
-
49
-
-
0028784523
-
Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine
-
Jackson-Lewis, V, Jakowec, M., Burke, R. E & Przedborski, S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine. Neurodegeneration 4, 257-269 (1995).
-
(1995)
Neurodegeneration
, vol.4
, pp. 257-269
-
-
Jackson-Lewis, V.1
Jakowec, M.2
Burke, R.E.3
Przedborski, S.4
-
50
-
-
0030888286
-
J. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl- 1, 2, 3, 6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining
-
Tatton, N. A. & Kish, S. J. In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl- 1, 2, 3, 6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining. Neuroscience 77, 1037-1048 (1997).
-
(1997)
Neuroscience 77
, pp. 1037-1048
-
-
Tatton, N.A.1
Kish, S.2
-
51
-
-
0035956874
-
Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine mouse model of Parkinson's disease
-
Vila, M. et al. Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine mouse model of Parkinson's disease. Proc. Nat Acad. Sci. USA 98, 2837-2842 (2001).
-
(2001)
Proc. Nat Acad. Sci. USA
, vol.98
, pp. 2837-2842
-
-
Vila, M.1
-
52
-
-
0032531886
-
1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J
-
Yang, L. et al. 1-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2. J. Neurosci. 18, 8145-8152 (1998).
-
(1998)
Neurosci
, vol.18
, pp. 8145-8152
-
-
Yang, L.1
-
53
-
-
0032510758
-
Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity
-
Offen, D. et al. Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine neurotoxicity. Proc. Nat Acad. Sci. USA 95, 5789-5794 (1998).
-
(1998)
Proc. Nat Acad. Sci. USA
, vol.95
, pp. 5789-5794
-
-
Offen, D.1
-
54
-
-
85047697335
-
A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes
-
Thornborrow, E. C., Patel, S., Mastropietro, A. E., Schwartzfarb, E. M. & Manfredi, J. J. A conserved intronic response element mediates direct p53-dependent transcriptional activation of both the human and murine bax genes. Oncogene 21, 990-999 (2002).
-
(2002)
Oncogene
, vol.21
, pp. 990-999
-
-
Thornborrow, E.C.1
Patel, S.2
Mastropietro, A.E.3
Schwartzfarb, E.M.4
Manfredi, J.J.5
-
55
-
-
0036788183
-
A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism
-
Mandir, A. S. et al. A novel in vivo post-translational modification of p53 by PARP-1 in MPTP-induced parkinsonism. J. Neurochem. 83, 186-192 (2002).
-
(2002)
J. Neurochem.
, vol.83
, pp. 186-192
-
-
Mandir, A.S.1
-
56
-
-
0033545925
-
Poly (ADP-ribose) polymerase activation mediates MPTP-induced parkinsonism
-
Mandir, A. S. et al. Poly (ADP-ribose) polymerase activation mediates MPTP-induced parkinsonism. Proc. NatlAcad. Sci. USA 96, 5774-5779 (1999).
-
(1999)
Proc. Natlacad. Sci. USA
, vol.96
, pp. 5774-5779
-
-
Mandir, A.S.1
-
57
-
-
0036829557
-
P53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism
-
Duan, W. et al. p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism. Ann. Neurol. 52, 597-606 (2002).
-
(2002)
Ann. Neurol.
, vol.52
, pp. 597-606
-
-
Duan, W.1
-
58
-
-
0030249597
-
Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity
-
Trimmer P A., Smith, T S., Jung, A. B. & Bennett, J. P Jr. Dopamine neurons from transgenic mice with a knockout of the p53 gene resist MPTP neurotoxicity. Neurodegeneraton 5, 233-239 (1996).
-
(1996)
Neurodegeneraton
, vol.5
, pp. 233-239
-
-
Trimmer, P.A.1
Smith, T.S.2
Jung, A.B.3
Bennett, J.P.4
-
59
-
-
0033840581
-
MPTP activates c-Jun NH2-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo
-
2-terminal kinase (JNK) and its upstream regulatory kinase MKK4 in nigrostriatal neurons in vivo. J. Neurochem. 75, 1200-1208 (2000).
-
(2000)
J. Neurochem.
, vol.75
, pp. 1200-1208
-
-
Saporito, M.S.1
Thomas, B.A.2
Scott, R.W.3
-
60
-
-
0035964358
-
Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease
-
Xia, X G. et al. Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease. Proc. NatlAcad. Sci. USA 98, 10433-10438 (2001).
-
(2001)
Proc. Natlacad. Sci. USA
, vol.98
, pp. 10433-10438
-
-
Xia, X.G.1
-
61
-
-
0033029823
-
CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo
-
Saporito, M. S., Brown, E. M., Miller, M. S. & Carswell, S. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo. J. Pharmacol exp. Tier. 288, 421-427 (1999).
-
(1999)
J. Pharmacol Exp. Tier.
, vol.288
, pp. 421-427
-
-
Saporito, M.S.1
Brown, E.M.2
Miller, M.S.3
Carswell, S.4
-
62
-
-
0034607702
-
Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway
-
Tournier, C. et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway Science 288, 875-874 (2000).
-
(2000)
Science
, vol.288
, pp. 875-874
-
-
Tournier, C.1
-
63
-
-
0036269755
-
The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun N-terminal kinase
-
Lei, K et al. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun N-terminal kinase. Mol. Cell Biol. 22, 4929-4942 (2002).
-
(2002)
Mol. Cell Biol.
, vol.22
, pp. 4929-4942
-
-
Lei, K.1
-
64
-
-
0035845532
-
An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease
-
Mochizuki, H. et al. An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease. Proc. Nat Acad. Sci. USA 98, 10918-10923 (2001).
-
(2001)
Proc. Nat Acad. Sci. USA
, vol.98
, pp. 10918-10923
-
-
Mochizuki, H.1
-
65
-
-
0034671450
-
Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease
-
Eberhardt, O. et al. Protection by synergistic effects of adenovirus-mediated X-chromosome-linked inhibitor of apoptosis and glial cell line-derived neurotrophic factor gene transfer in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease. J. Neurosci. 20, 9126-9134 (2000).
-
(2000)
J. Neurosci.
, vol.20
, pp. 9126-9134
-
-
Eberhardt, O.1
-
66
-
-
0036549215
-
Caspase inhibitors attenuate 1-methyl-4- phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons
-
Bilsland, J. et al. Caspase inhibitors attenuate 1-methyl-4- phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons. J. Neurosci. 22, 2637-2649 (2002).
-
(2002)
J. Neurosci.
, vol.22
, pp. 2637-2649
-
-
Bilsland, J.1
-
67
-
-
0037012844
-
Axonal self- destruction and neurodegeneration
-
Raff, M. C., Whitmore, A. V & Finn, J. T. Axonal self- destruction and neurodegeneration. Science 296, 868-871 (2002).
-
(2002)
Science
, vol.296
, pp. 868-871
-
-
Raff, M.C.1
Whitmore, A.V.2
Finn, J.T.3
-
68
-
-
0033912716
-
Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease
-
Chen, M. et al. Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nature Med. 6, 797-801 (2000).
-
(2000)
Nature Med
, vol.6
, pp. 797-801
-
-
Chen, M.1
-
69
-
-
0035807904
-
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
-
Du, Y. et al. Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. Proc Nat Acad. Sci. USA 98, 14669-14674 (2001).
-
(2001)
Proc Nat Acad. Sci. USA
, vol.98
, pp. 14669-14674
-
-
Du, Y.1
-
70
-
-
0036522967
-
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine mouse model of Parkinson disease
-
Wu, D. C. et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine mouse model of Parkinson disease. J. Neurosci. 22, 1763-1771 (2002).
-
(2002)
J. Neurosci.
, vol.22
, pp. 1763-1771
-
-
Wu, D.C.1
-
71
-
-
0030744876
-
Mutation in the a-synuclein gene identified in families with Parkinson's disease
-
Polymeropoulos, M. H. et al. Mutation in the a-synuclein gene identified in families with Parkinson's disease. Science 276. 2045-2047 (1997).
-
(1997)
Science
, vol.276
, pp. 2045-2047
-
-
Polymeropoulos, M.H.1
-
72
-
-
0031990490
-
Ala30Pro mutation in the gene encoding a-synuclein in Parkinson's disease
-
Kruger, R. et al. Ala30Pro mutation in the gene encoding a-synuclein in Parkinson's disease. Nature Genet. 18, 107-108 (1998).
-
(1998)
Nature Genet
, vol.18
, pp. 107-108
-
-
Kruger, R.1
-
73
-
-
0030882856
-
A-Synuclein in Lewy bodies
-
Spillantini, M. G. et al. a-Synuclein in Lewy bodies. Nature 388, 839-840 (1997).
-
(1997)
Nature
, vol.388
, pp. 839-840
-
-
Spillantini, M.1
-
74
-
-
0033966487
-
A-Synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP
-
Vila, M. et al. a-Synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J. Neurochem. 74, 721-729 (2000).
-
(2000)
J. Neurochem.
, vol.74
, pp. 721-729
-
-
Vila, M.1
-
75
-
-
0035144650
-
Oxidative post-translational modifications of a-synuclein in the 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine (MPTP) mouse model of Parkinson's disease
-
Przedborski, S. et al. Oxidative post-translational modifications of a-synuclein in the 1-methyl-4-phenyl-1, 2, 3, 6- tetrahydropyridine (MPTP) mouse model of Parkinson's disease. J. Neurochem. 76, 637-640 (2001).
-
(2001)
J. Neurochem.
, vol.76
, pp. 637-640
-
-
Przedborski, S.1
-
76
-
-
0037195109
-
Resistance of a-synuclein null mice to the parkinsonian neurotoxin MPTP
-
Dauer, W. et al. Resistance of a-synuclein null mice to the parkinsonian neurotoxin MPTP Proc. Nat Acad. Sci. USA 99, 14524-14529 (2002).
-
(2002)
Proc. Nat Acad. Sci. USA
, vol.99
, pp. 14524-14529
-
-
Dauer, W.1
-
77
-
-
0032573597
-
Aggregates from mutant and wild-type a-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of p-sheet and amyloid-like filaments
-
El-Agnaf, O. M. et al. Aggregates from mutant and wild-type a-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of p-sheet and amyloid-like filaments. FEBS Lett. 440, 71-75 (1998).
-
(1998)
FEBS Lett
, vol.440
, pp. 71-75
-
-
El-Agnaf, O.M.1
-
78
-
-
0032879452
-
Role of cytochrome c as a stimulator of a-synuclein aggregation in Lewy body disease
-
Hashimoto, M., Takeda, A., Hsu, L J., Takenouchi, T. & Masliah, E. Role of cytochrome c as a stimulator of a-synuclein aggregation in Lewy body disease. J. Biol. Chem. 274, 28849-28852 (1999).
-
(1999)
J. Biol. Chem.
, vol.274
, pp. 28849-28852
-
-
Hashimoto, M.1
Takeda, A.2
Hsu, L.J.3
Takenouchi, T.4
Masliah, E.5
-
79
-
-
0035815285
-
Release and aggregation of cytochrome c and a-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole
-
Kakimura, J. et al. Release and aggregation of cytochrome c and a-synuclein are inhibited by the antiparkinsonian drugs, talipexole and pramipexole. Eur. J. Pharmacol. 417, 59-67 (2001).
-
(2001)
Eur. J. Pharmacol.
, vol.417
, pp. 59-67
-
-
Kakimura, J.1
-
80
-
-
0024557734
-
Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains
-
Riederer, P et al. Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J. Neurochem. 52, 515-520 (1989).
-
(1989)
J. Neurochem.
, vol.52
, pp. 515-520
-
-
Riederer, P.1
-
81
-
-
0032317298
-
Direct evidence for glutathione as mediator of apoptosis in neuronal cells
-
Nicole, A., Santiard-Baron, D. & Ceballos-Picot, I. Direct evidence for glutathione as mediator of apoptosis in neuronal cells. Biomed. Phanmacotfier 52, 349-355 (1998).
-
(1998)
Biomed. Phanmacotfier
, vol.52
, pp. 349-355
-
-
Nicole, A.1
Santiard-Baron, D.2
Ceballos-Picot, I.3
-
82
-
-
0004052707
-
Merritt's textbook of neurology
-
Rowland, L. P, Lippincott, Williams & Wilkins, Philadelphia
-
Rowland, L. P. Merritt's textbook of neurology (ed. Rowland, L. P) 742-749 (Lippincott, Williams & Wilkins, Philadelphia, 1995).
-
(1995)
, pp. 742-749
-
-
Rowland, L.P.1
-
83
-
-
0028284779
-
Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation
-
Gurney, M. E. et al. Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772-1775 (1994).
-
(1994)
Science
, vol.264
, pp. 1772-1775
-
-
Gurney, M.E.1
-
84
-
-
0029053881
-
An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria
-
Wong, P. C. et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116 (1995).
-
(1995)
Neuron
, vol.14
, pp. 1105-1116
-
-
Wong, P.C.1
-
85
-
-
0031051485
-
ALS-linked SOD1 mutant G85R mediated damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions
-
Bruijn, L. I. et al. ALS-linked SOD1 mutant G85R mediated damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 18, 327-338 (1997).
-
(1997)
Neuron
, vol.18
, pp. 327-338
-
-
Bruijn, L.I.1
-
86
-
-
0035575761
-
Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: Associated mutations develop motor neuron disease
-
Nagai, M. et al. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J. Neurosci. 21, 9246-9254 (2001).
-
(2001)
J. Neurosci.
, vol.21
, pp. 9246-9254
-
-
Nagai, M.1
-
87
-
-
0036212119
-
Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading
-
Subramaniam, J. R. et al. Mutant SOD1 causes motor neuron disease independent of copper chaperone-mediated copper loading. Nature Neurosci. 5, 301 -307 (2002).
-
(2002)
Nature Neurosci
, vol.5
-
-
Subramaniam, J.R.1
-
88
-
-
15844393658
-
Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury
-
Reaume, A. G. et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nature Genet. 13, 43-47 (1996).
-
(1996)
Nature Genet
, vol.13
, pp. 43-47
-
-
Reaume, A.G.1
-
89
-
-
0029584941
-
Superoxide dismutase in familial amyotrophic lateral sclerosis: Models for gain of function
-
Brown, R. H. Jr. Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function. Curr. Opin. Neurobiol. 5, 841-846 (1995).
-
(1995)
Curr. Opin. Neurobiol.
, vol.5
, pp. 841-846
-
-
Brown, R.H.1
-
90
-
-
0028915976
-
Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: Studies in yeast and neural cells
-
Rabizadeh, S. et al. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc. NatlAcad. Sci. USA 92, 3024-3028 (1995).
-
(1995)
Proc. Natlacad. Sci. USA
, vol.92
, pp. 3024-3028
-
-
Rabizadeh, S.1
-
91
-
-
0030831352
-
Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: Molecular mechanisms of neuronal death and protection
-
Ghadge, G. D. et al. Mutant superoxide dismutase-1-linked familial amyotrophic lateral sclerosis: molecular mechanisms of neuronal death and protection. J. Neurosci. 17, 8756-8766 (1997).
-
(1997)
J. Neurosci.
, vol.17
, pp. 8756-8766
-
-
Ghadge, G.D.1
-
92
-
-
0030943110
-
Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture
-
Mena, M. A. et al. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J. Neurochem. 69, 21 -33 (1997).
-
(1997)
J. Neurochem
, vol.69
-
-
Mena, M.A.1
-
93
-
-
0030756459
-
Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis
-
Kostic, V, Jackson-Lewis, V, De Bilbao, F, Dubois-Dauphin, M. & Przedborski, S. Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277, 559-562 (1997).
-
(1997)
Science
, vol.277
, pp. 559-562
-
-
Kostic, V.1
Jackson-Lewis, V.2
De Bilbao, F.3
Dubois-Dauphin, M.4
Przedborski, S.5
-
94
-
-
0034647003
-
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
-
Li, M. et al. Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science 288, 335-339 (2000).
-
(2000)
Science
, vol.288
, pp. 335-339
-
-
Li, M.1
-
95
-
-
0037240427
-
Programmed cell death in amyotrophic lateral sclerosis
-
Guegan, C. & Przedborski, S. Programmed cell death in amyotrophic lateral sclerosis. J. Clin. Invest. 111, 153-161 (2003).
-
(2003)
J. Clin. Invest.
, vol.111
, pp. 153-161
-
-
Guegan, C.1
Przedborski, S.2
-
96
-
-
0035516124
-
From Charcot to Lou Gehrig: Deciphering selective motor neuron death in ALS
-
Cleveland, D. W. & Rothstein, J. D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Rev. Neurosci. 2, 806-819 (2001).
-
(2001)
Nature Rev. Neurosci.
, vol.2
, pp. 806-819
-
-
Cleveland, D.W.1
Rothstein, J.D.2
-
97
-
-
0020391974
-
Aspects of the ultrastructure of amyotrophic lateral sclerosis
-
Hirano, A. Aspects of the ultrastructure of amyotrophic lateral sclerosis. Adv. Neurol. 36, 75-88 (1982).
-
(1982)
Adv. Neurol.
, vol.36
, pp. 75-88
-
-
Hirano, A.1
-
98
-
-
0032896327
-
Neuronal death in amyotrophic lateral sclerosis is apoptosis: Possible contribution of a programmed cell death mechanism
-
Martin, L J. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J. Neuropathol. Exp. Neurol 58, 459-471 (1999).
-
(1999)
J. Neuropathol. Exp. Neurol
, vol.58
, pp. 459-471
-
-
Martin, L.J.1
-
99
-
-
0034671376
-
Delaying caspase activation by Bcl-2: A clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis
-
Vukosavic, S. et al. Delaying caspase activation by Bcl-2: a clue to disease retardation in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 20, 9119-9125 (2000).
-
(2000)
J. Neurosci.
, vol.20
, pp. 9119-9125
-
-
Vukosavic, S.1
-
100
-
-
0034610328
-
Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis
-
Pasinelli, P, Houseweart, M. K, Brown, R. H. Jr & Cleveland, D. W. Caspase-1 and -3 are sequentially activated in motor neuron death in Cu, Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 97, 13901-13906 (2000).
-
(2000)
Proc. Natl Acad. Sci. USA
, vol.97
, pp. 13901-13906
-
-
Pasinelli, P.1
Houseweart, M.K.2
Brown, R.H.3
Cleveland, D.W.4
-
101
-
-
0027946294
-
Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis
-
Dal Canto, M. C. & Gurney, M. E. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am. J. Pathol. 145. 1271-1279 (1994).
-
(1994)
Am. J. Pathol.
, vol.145
, pp. 1271-1279
-
-
Dal Canto, M.C.1
Gurney, M.E.2
-
102
-
-
0028101227
-
Apoptosis related antigen, LeY and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis
-
Y and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol. (Berl.) 88, 207-211 (1994).
-
(1994)
Acta Neuropathol. (Berl.)
, vol.88
, pp. 207-211
-
-
Yoshiyama, Y.1
Yamada, T.2
Asanuma, K.3
Asahi, T.4
-
103
-
-
0032862513
-
Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons
-
Ekegren, T, Grundstrom, E., Lindholm, D. & Aquilonius, S. M. Upregulation of Bax protein and increased DNA degradation in ALS spinal cord motor neurons. Acta Neurol. Scand. 100. 317-321 (1999).
-
(1999)
Acta Neurol. Scand.
, vol.100
, pp. 317-321
-
-
Ekegren, T.1
Grundstrom, E.2
Lindholm, D.3
Aquilonius, S.M.4
-
104
-
-
0027985477
-
A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks
-
Migheli, A., Cavalla, P, Marino, S. & Schiffer D. A study of apoptosis in normal and pathologic nervous tissue after in situ end-labeling of DNA strand breaks. J. Neuropathol. Exp. Neurol. 53, 606-616 (1994).
-
(1994)
J. Neuropathol. Exp. Neurol.
, vol.53
, pp. 606-616
-
-
Migheli, A.1
Cavalla, P.2
Marino, S.3
Schiffer, D.4
-
105
-
-
0032863462
-
Lack of apoptosis in mice with ALS
-
Migheli, A. et al. Lack of apoptosis in mice with ALS. Nature Med. 5, 966-967 (1999).
-
(1999)
Nature Med
, vol.5
, pp. 966-967
-
-
Migheli, A.1
-
106
-
-
0033625507
-
Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits
-
He, B. P. & Strong, M. J. Motor neuronal death in sporadic amyotrophic lateral sclerosis (ALS) is not apoptotic. A comparative study of ALS and chronic aluminium chloride neurotoxicity in New Zealand white rabbits. Neuropathol. Appl. Neurobiol. 26, 150-160 (2000).
-
(2000)
Neuropathol. Appl. Neurobiol.
, vol.26
, pp. 150-160
-
-
He, B.P.1
Strong, M.J.2
-
107
-
-
0034012013
-
The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis
-
Pedersen, W. A., Luo, H., Kruman, I., Kasarskis, E. & Mattson, M. P. The prostate apoptosis response-4 protein participates in motor neuron degeneration in amyotrophic lateral sclerosis. FASEB J. 14, 913-924 (2000).
-
(2000)
FASEB J
, vol.14
, pp. 913-924
-
-
Pedersen, W.A.1
Luo, H.2
Kruman, I.3
Kasarskis, E.4
Mattson, M.P.5
-
108
-
-
0029787513
-
Altered expression of bc!-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons
-
Mu, X., He, J., Anderson, D. W., Trojanowski, J. Q. & Springer J. E. Altered expression of bc!-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 40, 379-386 (1996).
-
(1996)
Ann. Neurol.
, vol.40
, pp. 379-386
-
-
Mu, X.1
He, J.2
Erson, D.W.3
Trojanowski, J.Q.4
Springer, J.E.5
-
109
-
-
0032750753
-
Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis
-
Vukosavic, S., Dubois-Dauphin, M., Romero, N. & Przedborski, S. Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 73, 2460-2468 (1999).
-
(1999)
J. Neurochem.
, vol.73
, pp. 2460-2468
-
-
Vukosavic, S.1
Dubois-Dauphin, M.2
Romero, N.3
Przedborski, S.4
-
110
-
-
0029563461
-
Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post- central gyrus
-
Troost, D., Aten, J., Morsink, F. & De Jong, J. M. B. V Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected post- central gyrus. Neuropathol.Appl. NeuroBiol. 21. 498-504 (1995).
-
(1995)
Neuropathol.Appl. Neurobiol.
, vol.21
, pp. 498-504
-
-
Troost, D.1
Aten, J.2
Morsink, F.3
De Jong, J.4
-
111
-
-
0033826143
-
Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: Evidence for the implication of the p53 signaling pathway
-
Gonzalez de Aguilar, J. L. et al. Alteration of the Bcl-x/Bax ratio in a transgenic mouse model of amyotrophic lateral sclerosis: evidence for the implication of the p53 signaling pathway. NeuroBiol. Dis. 7, 406-415 (2000).
-
(2000)
Neurobiol. Dis.
, vol.7
, pp. 406-415
-
-
Gonzalez De Aguilar, J.L.1
-
112
-
-
0035437866
-
Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis
-
Guegan, C., Vila, M., Rosoklija, G., Hays, A. P & Przedborski, S. Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis. J. Neurosci. 21. 6569-6576 (2001).
-
(2001)
J. Neurosci.
, vol.21
, pp. 6569-6576
-
-
Guegan, C.1
Vila, M.2
Rosoklija, G.3
Hays, A.P.4
Przedborski, S.5
-
113
-
-
0034517935
-
P53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis
-
Martin, L J. p53 is abnormally elevated and active in the CNS of patients with amyotrophic lateral sclerosis. NeuroBiol. Dis. 7, 613-622 (2000).
-
(2000)
Neurobiol. Dis.
, vol.7
, pp. 613-622
-
-
Martin, L.J.1
-
114
-
-
0034613225
-
Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator
-
Prudlo, J. et al. Motor neuron cell death in a mouse model of FALS is not mediated by the p53 cell survival regulator. Brain Res. 879, 183-187 (2000).
-
(2000)
Brain Res
, vol.879
, pp. 183-187
-
-
Prudlo, J.1
-
115
-
-
0033834503
-
Absence of p53: No effect in a transgenic mouse model of familial amyotrophic lateral sclerosis
-
Kuntz, C., Kinoshita, Y, Beal, M. F., Donehower, L. A. & Morrison, R. S. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp. Neurol. 165, 184-190 (2000).
-
(2000)
Exp. Neurol.
, vol.165
, pp. 184-190
-
-
Kuntz, C.1
Kinoshita, Y.2
Beal, M.F.3
Donehower, L.A.4
Morrison, R.S.5
-
116
-
-
0036385720
-
Instrumental activation of Bid by caspase-1 in a transgenic mouse model of ALS
-
Guegan, C. et al. Instrumental activation of Bid by caspase-1 in a transgenic mouse model of ALS. Mol. Cell. Neurosci. 20. 553 (2002).
-
(2002)
Mol. Cell. Neurosci.
, vol.20
, pp. 553
-
-
Guegan, C.1
-
117
-
-
1842407161
-
Inhibition of ICE slows ALS in mice
-
Friedlander, R. M., Brown, R. H., Gagliardini, V, Wang, J. & Yuan, J. Inhibition of ICE slows ALS in mice. Nature 388, 31 (1997).
-
(1997)
Nature
, vol.388
, pp. 31
-
-
Friedlander, R.M.1
Brown, R.H.2
Gagliardini, V.3
Wang, J.4
Yuan, J.5
-
118
-
-
0037007645
-
Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice
-
Zhu, S. et al. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417, 74-78 (2002).
-
(2002)
Nature
, vol.417
, pp. 74-78
-
-
Zhu, S.1
-
119
-
-
0036326423
-
X-Linked inhibitor of apoptosis protein is involved in mutant SOD1- mediated neuronal degeneration
-
Ishigaki, S. et al. X-Linked inhibitor of apoptosis protein is involved in mutant SOD1- mediated neuronal degeneration. J. Neurochem. 82, 576-584 (2002).
-
(2002)
J. Neurochem.
, vol.82
, pp. 576-584
-
-
Ishigaki, S.1
-
120
-
-
0033615957
-
Programmed cell death of embryonic motoneurons triggered through the Fas death receptor
-
Raoul, C., Henderson, C. E. & Pettmann, B. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol. 147, 1049-1062 (1999).
-
(1999)
J. Cell Biol.
, vol.147
, pp. 1049-1062
-
-
Raoul, C.1
Henderson, C.E.2
Pettmann, B.3
-
121
-
-
0037068836
-
Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations
-
Raoul, C. et al. Motoneuron death triggered by a specific pathway downstream of Fas. Potentiation by ALS-linked SOD1 mutations. Neuron 35, 1067-1083 (2002).
-
(2002)
Neuron
, vol.35
, pp. 1067-1083
-
-
Raoul, C.1
-
122
-
-
0034765498
-
Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: No requirement for proapoptotic interleukin-1 p in neurodegeneration
-
Nguyen, M. D., Julien, J. P. & Rivest, S. Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1 p in neurodegeneration. Ann. Neurol. 50, 630-639 (2001).
-
(2001)
Ann. Neurol.
, vol.50
, pp. 630-639
-
-
Nguyen, M.D.1
Julien, J.P.2
Rivest, S.3
-
123
-
-
0029925184
-
Trinucleotide repeat length and clinical progression in Huntington's disease
-
Brandt, J. et al. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology 46, 527-531 (1996).
-
(1996)
Neurology
, vol.46
, pp. 527-531
-
-
Brandt, J.1
-
124
-
-
16044373842
-
Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice
-
Mangiarini, L. et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87, 493-506 (1996).
-
(1996)
Cell 87
, pp. 493-506
-
-
Mangiarini, L.1
-
125
-
-
0029086807
-
DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions
-
Thomas, L B. et al. DNA end labeling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp. Neurol 133, 265-272 (1995).
-
(1995)
Exp. Neurol
, vol.133
, pp. 265-272
-
-
Thomas, L.B.1
-
126
-
-
0029072690
-
Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models
-
Portera-Cailliau, C., Hedreen, J. C., Price, D. L & Koliatsos, V. E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15, 3775-3787 (1995).
-
(1995)
J. Neurosci.
, vol.15
, pp. 3775-3787
-
-
Portera-Cailliau, C.1
Hedreen, J.C.2
Price, D.L.3
Koliatsos, V.E.4
-
127
-
-
0033587128
-
Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease
-
Ona, V O. et al. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399, 263-267 (1999).
-
(1999)
Nature
, vol.399
, pp. 263-267
-
-
Ona, V.O.1
-
128
-
-
0033103523
-
Caspase-8 is required for cell death induced by expanded polyglutamine repeats
-
Sanchez, I. et al. Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22, 623-633 (1999).
-
(1999)
Neuron
, vol.22
, pp. 623-633
-
-
Sanchez, I.1
-
129
-
-
0033914471
-
Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant
-
Andreassen, O. A. et al. Malonate and 3-nitropropionic acid neurotoxicity are reduced in transgenic mice expressing a caspase-1 dominant-negative mutant. J. Neurochem. 75, 847-852 (2000).
-
(2000)
J. Neurochem.
, vol.75
, pp. 847-852
-
-
Andreassen, O.A.1
-
130
-
-
0037418339
-
Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice
-
Duan, W. et al. Dietary restriction normalizes glucose metabolism and BDNF levels, slows disease progression, and increases survival in huntingtin mutant mice. Proc. Natl Acad. Sci. USA 100, 2911-2916 (2003).
-
(2003)
Proc. Natl Acad. Sci. USA
, vol.100
, pp. 2911-2916
-
-
Duan, W.1
-
131
-
-
0033591047
-
Expression of extended polyglutamine sequentially activates initiator and effector caspases
-
Miyashita, T et al. Expression of extended polyglutamine sequentially activates initiator and effector caspases. Biochem. Biophys. Res. Commun. 257, 724-730 (1999).
-
(1999)
Biochem. Biophys. Res. Commun
, vol.257
, pp. 724-730
-
-
Miyashita, T.1
-
132
-
-
0035805504
-
Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing
-
Rigamonti, D. et al. Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing. J. Biol. Chem. 276, 1454-14548 (2001).
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 1454-14548
-
-
Rigamonti, D.1
-
133
-
-
9344227302
-
Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract
-
Goldberg, Y. P. et al. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet 13, 442-449 (1996).
-
(1996)
Nature Genet
, vol.13
, pp. 442-449
-
-
Goldberg, Y.P.1
-
134
-
-
0032502715
-
Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract
-
Wellington, C. L et al. Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273, 9158-9167 (1998).
-
(1998)
J. Biol. Chem
, vol.273
, pp. 9158-9167
-
-
Wellington, C.L.1
-
135
-
-
0034733607
-
Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells
-
Wellington, C. L et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275. 19831 -19838 (2000).
-
(2000)
J. Biol. Chem.
, vol.275
-
-
Wellington, C.L.1
-
136
-
-
17344363559
-
Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates
-
Martindale, D. et al. Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates. Nature Genet. 18, 150-154 (1998).
-
(1998)
Nature Genet
, vol.18
, pp. 150-154
-
-
Martindale, D.1
-
137
-
-
0028989602
-
Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
-
DiFiglia, M. et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081 (1995).
-
(1995)
Neuron
, vol.14
, pp. 1075-1081
-
-
Difiglia, M.1
-
138
-
-
0035940412
-
Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis
-
Kim, Y. J. et al. Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl Acad. Sci. USA 98, 12784-12789 (2001).
-
(2001)
Proc. Natl Acad. Sci. USA 98
, pp. 12784-12789
-
-
Kim, Y.J.1
-
139
-
-
0035869544
-
Tissue-specific proteolysis of Huntingtin (Htt) in human brain: Evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum
-
Mende-Mueller, L M., Toneff, T, Hwang, S. R., Chesselet, M. F. & Hook, V. Y. Tissue-specific proteolysis of Huntingtin (htt) in human brain: evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J. Neurosci. 21, 1830-1837 (2001).
-
(2001)
J. Neurosci.
, vol.21
, pp. 1830-1837
-
-
Mende-Mueller, L.M.1
Toneff, T.2
Hwang, S.R.3
Chesselet, M.F.4
Hook, V.Y.5
-
140
-
-
0037107151
-
Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease
-
Wellington, C. L et al. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22, 7862-7872 (2002).
-
(2002)
J. Neurosci.
, vol.22
, pp. 7862-7872
-
-
Wellington, C.L.1
-
141
-
-
0036173770
-
Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi
-
Gervais, F G. et al. Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi. Nature Cell Biol. 4, 95-105 (2002).
-
(2002)
Nature Cell Biol
, vol.4
, pp. 95-105
-
-
Gervais, F.G.1
-
142
-
-
0034641932
-
From bench to clinic with apoptosis-based therapeutic agents
-
Nicholson, D. W. From bench to clinic with apoptosis-based therapeutic agents. Nature 407, 810-816 (2000).
-
(2000)
Nature
, vol.407
, pp. 810-816
-
-
Nicholson, D.W.1
-
143
-
-
0027257708
-
Apoptosis is induced by p-amyloid in cultured central nervous system neurons
-
Loo, D. T. et al. Apoptosis is induced by p-amyloid in cultured central nervous system neurons. Proc. Natl Acad. Sci. USA 90, 7951 -7955 (1993).
-
(1993)
Proc. Natl Acad. Sci. USA
, vol.90
-
-
Loo, D.T.1
-
144
-
-
0028577208
-
W Immunohistochemical evidence for apoptosis in Alzheimer's disease
-
Su, J. H., Anderson, A. J., Cummings, B. J. & Cotman, C. W Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport 5, 2529-2533 (1994).
-
(1994)
Neuroreport
, vol.5
, pp. 2529-2533
-
-
Su, J.H.1
Erson, A.J.2
Cummings, B.J.3
Cotman, C.4
-
145
-
-
0032747486
-
Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death
-
Stadelmann, C. et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am. J. Pathol. 155, 1459-1466 (1999).
-
(1999)
Am. J. Pathol.
, vol.155
, pp. 1459-1466
-
-
Stadelmann, C.1
-
146
-
-
0032873466
-
In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease
-
Selznick, L. A. et al. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J. Neuropathol. Exp. Neurol. 58, 1020-1026 (1999).
-
(1999)
J. Neuropathol. Exp. Neurol
, vol.58
-
-
Selznick, L.A.1
-
147
-
-
0035664134
-
Activation of caspase-8 in the Alzheimer's disease brain
-
Rohn, T T, Head, E., Nesse, W. H., Cotman, C. W. & Cribbs, D. H. Activation of caspase-8 in the Alzheimer's disease brain. NeuroBiol. Dis. 8, 1020-1016 (2001).
-
(2001)
Neurobiol. Dis.
, vol.8
, pp. 1020-1016
-
-
Rohn, T.T.1
Head, E.2
Nesse, W.H.3
Cotman, C.W.4
Cribbs, D.H.5
-
148
-
-
0036968953
-
Caspase-9 Activation and caspase cleavage of tau in the Alzheimer's disease brain
-
Rohn, T T et al. Caspase-9 Activation and caspase cleavage of tau in the Alzheimer's disease brain. NeuroBiol. Dis. 11. 341 -354 (2002).
-
(2002)
Neurobiol. Dis.
, vol.11
-
-
Rohn, T.T.1
-
149
-
-
0032726814
-
Neuronal apoptosis induced by p-amyloid is mediated by caspase-8
-
Ivins, K J., Thornton, P. L., Rohn, T. T. & Cotman, C. W. Neuronal apoptosis induced by p-amyloid is mediated by caspase-8. NeuroBiol. Dis. 6, 440-449 (1999).
-
(1999)
Neurobiol. Dis.
, vol.6
, pp. 440-449
-
-
Ivins, K.J.1
Thornton, P.L.2
Rohn, T.T.3
Cotman, C.W.4
-
150
-
-
0034697299
-
E2F1 mediates death of p-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3
-
Giovanni, A. et al. E2F1 mediates death of p-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J. Biol. Chem. 275, 11553-11560 (2000).
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 11553-11560
-
-
Giovanni, A.1
-
151
-
-
0034652232
-
Caspase-2 mediates neuronal cell death induced by p-amyloid
-
Troy, C. M. et al. Caspase-2 mediates neuronal cell death induced by p-amyloid. J. Neurosci. 20, 1386-1392 (2000).
-
(2000)
J. Neurosci.
, vol.20
, pp. 1386-1392
-
-
Troy, C.M.1
-
152
-
-
0033617402
-
Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-p precursor protein and amyloidogenic Ap peptide formation
-
Gervais, F. G. et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-p precursor protein and amyloidogenic Ap peptide formation. Cell 97, 395-406 (1999).
-
(1999)
Cell
, vol.97
, pp. 395-406
-
-
Gervais, F.G.1
-
153
-
-
0034107524
-
A second cytotoxic proteolytic peptide derived from amyloid-p protein precursor
-
Lu, D. C. et al. A second cytotoxic proteolytic peptide derived from amyloid-p protein precursor. Nature Med. 6, 397-404 (2000).
-
(2000)
Nature Med
, vol.6
, pp. 397-404
-
-
Lu, D.C.1
-
154
-
-
0020680904
-
Chronic parkinsonism in humans due to a product of meperidine-analog synthesis
-
Langston, J. W., Ballard, P & Irwin, I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980 (1983).
-
(1983)
Science
, vol.219
, pp. 979-980
-
-
Langston, J.W.1
Ballard, P.2
Irwin, I.3
-
155
-
-
0023093745
-
MPTP! MPP+ and mitochondrial Unction
-
Nicklas, W. J., Yougster, S. K., Kindt, M. V & Heikkila, R. E. MPTP! MPP+ and mitochondrial Unction. Life Sci. 40, 721-729 (1987).
-
(1987)
Life Sci
, vol.40
, pp. 721-729
-
-
Nicklas, W.J.1
Yougster, S.K.2
Kindt, M.V.3
Heikkila, R.E.4
-
156
-
-
0028142644
-
Studies on the characterization of the inhibitory mechanism of 4'-alkylated 1-methyl-4-phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles
-
Gluck, M. R., Youngster, S. K, Ramsay, R. R., Singer, T P & Nicklas, W. J. Studies on the characterization of the inhibitory mechanism of 4'-alkylated 1-methyl-4-phenylpyridinium and phenylpyridine analogues in mitochondria and electron transport particles. J. Neurochem. 63, 655-661 (1994).
-
(1994)
J. Neurochem.
, vol.63
, pp. 655-661
-
-
Gluck, M.R.1
Youngster, S.K.2
Ramsay, R.R.3
Singer, T.P.4
Nicklas, W.J.5
-
157
-
-
0027401203
-
Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis
-
Rosen, D. R. et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59-62 (1993).
-
(1993)
Nature
, vol.362
, pp. 59-62
-
-
Rosen, D.R.1
-
158
-
-
0027426169
-
Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase
-
Deng, H.-X et al. Amyotrophic lateral sclerosis and structural defects in Cu, Zn superoxide dismutase. Science 261. 1047-1051 (1993).
-
(1993)
Science
, vol.261
, pp. 1047-1051
-
-
Deng, H.-X.1
-
159
-
-
0029096114
-
Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis
-
Chiu, A. Y et al. Age-dependent penetrance of disease in a transgenic mouse model of familial amyotrophic lateral sclerosis. Mol. Cell. Neurosci. 6, 349-362 (1995).
-
(1995)
Mol. Cell. Neurosci.
, vol.6
, pp. 349-362
-
-
Chiu, A.Y.1
-
160
-
-
0028933344
-
Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS)
-
Dal Canto, M. C. & Gurney, M. E. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu, Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS). Brain Res. 676, 25-40 (1995).
-
(1995)
Brain Res
, vol.676
, pp. 25-40
-
-
Dal Canto, M.C.1
Gurney, M.E.2
-
161
-
-
0033018506
-
Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis
-
Almer, G., Vukosavic, S., Romero, N. & Przedborski, S. Inducible nitric oxide synthase upregulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 72, 2415-2425 (1999).
-
(1999)
J. Neurochem.
, vol.72
, pp. 2415-2425
-
-
Almer, G.1
Vukosavic, S.2
Romero, N.3
Przedborski, S.4
-
162
-
-
0029966363
-
Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions
-
Tu, P. H. et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl Acad. Sci. USA 93, 3155-3160 (1996).
-
(1996)
Proc. Natl Acad. Sci. USA
, vol.93
, pp. 3155-3160
-
-
Tu, P.H.1
-
163
-
-
84984755683
-
Cyclooxygenase-2 is instrumental in Parkinson disease neurodegeneration
-
Teismann, P. et al. Cyclooxygenase-2 is instrumental in Parkinson disease neurodegeneration. Proc. Natl Acad. Sci. USA (in the press).
-
Proc. Natl Acad. Sci. USA
-
-
Teismann, P.1
|